Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Rectal Neoplasms 2Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Anemia 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Smoking Cessation 1Papillomavirus Infections 1Pancreatic Neoplasms 1Pain 1Neutropenia 1Neurotoxicity Syndromes 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lymphoma 1Hypothyroidism 1Human Papillomavirus-Related Cervical Carcinoma 1Hepatitis C, Chronic 1Hepatitis C 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Fibrosis 1Fatigue 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Diabetes Mellitus 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 1adacel 1Tetanus Toxoid 1Human Papillomavirus Recombinant Vaccine nonavalent 1Diphtheria-Tetanus-acellular Pertussis Vaccines 1Diphtheria Toxoid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × NIH × Human Papillomavirus-Related Cervical Carcinoma × Clear all
NCT05237947 2026-05-28

PRISMA

National Cancer Institute (NCI)

Phase 4 Active not recruiting
5,000 enrolled
Gynecologic

Human Papillomavirus-Related Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡